Disease | artery disease |
Phenotype | |diabetes mellitus |
Sentences | 76 |
PubMedID- 20347119 | Introduction: type 2 diabetes mellitus (dm) patients with coronary artery disease (cad) have elevated plasma oxidized-ldl (oxldl) levels and impaired neovascularization. |
PubMedID- 26244031 | The everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (essence-diabetes) randomized study compared ees (n=149) and ses (n=151) implantation in diabetic patients. |
PubMedID- 24282409 | This review examines potential biological markers, ykl-40, alpha-hydroxybutyrate, soluble cd36, leptin, resistin, interleukin-18, retinol binding protein-4, and chemerin, as they may play significant roles in insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. |
PubMedID- 23431252 | There was no statistically significant difference between the two groups in hypertension, diabetes mellitus, smoking, history of coronary artery disease, preinfarction angina, and previous history of mi (p > 0.05). |
PubMedID- 22276258 | Screening for coronary artery disease in patients with type 2 diabetes mellitus: an evidence-based review. |
PubMedID- 24600114 | Background: the mortality and morbidity rates are two to fourfold higher among coronary artery disease (cad) patients with type 2 diabetes mellitus (dm). |
PubMedID- 25018979 | Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. |
PubMedID- 24667131 | Reported the coronary angiography data suggesting that small chylomicron remnants were implicated in the progression of coronary artery diseases in patients with type 2 diabetes mellitus [26]. |
PubMedID- 25938439 | Ir plays a key role in the pathogenesis of atherosclerosis, from the initiation and progression of disease to the formation of clinically significant plaques and coronary artery disease, even in patients without diabetes mellitus [9–11]. |
PubMedID- 23272439 | Conclusion: presence of diabetes mellitus is associated with diffuse coronary artery disease and significant carotid artery disease in patients undergoing coronary artery bypass grafting. |
PubMedID- 21507365 | Opposing effects of beta blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. |
PubMedID- 24273550 | Decreased mirna-126 was also found in atherosclerotic coronary artery disease (cad) and in patients with type 2 diabetes mellitus and may reflect the condition of vascular endothelial cells in heart failure patients (fukushima et al., 2011). |
PubMedID- 22528595 | Diagnosis of coronary artery disease in persons with diabetes mellitus. |
PubMedID- 21063711 | 2segmental coronary artery disease in patients with and without diabetes mellitus. |
PubMedID- 21386092 | Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. |
PubMedID- 23230096 | The study on the prognosis and effect of antidiabetic drugs on type 2 diabetes mellitus with coronary artery disease (spread-dimcad) was a prospective, randomized, double-blind, placebo-controlled trial that evaluated the different effects of glipizide and metformin on the major cardiovascular events and mortality among type 2 diabetic patients with a history of cad. |
PubMedID- 22666259 | Exclusion criteria were diabetes mellitus, history of coronary artery disease, congestive heart failure, congenital or acquired arrhythmia syndromes, use of drugs that lengthen the qt interval, current af, bundle branch block, atrioventricular blocks, and unmeasurable t waves (<0.15 mv) on surface ecg. |
PubMedID- 22140324 | Among the risk factors identified for acs in this group are hypercholesterolemia, hypertension, diabetes mellitus, family history of coronary artery disease (cad), and cigarette smoking. |
PubMedID- 26342170 | Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review. |
PubMedID- 20591621 | Methods: individuals aged < or = 65 years not taking statins and without diabetes mellitus or histories of coronary artery disease underwent cimt and plaque examination for primary prevention. |
PubMedID- 24821368 | Objective: the aim of this study was to examine the impact of cyp2c19 genotype on clinical outcome in coronary artery disease (cad) patients with or without diabetes mellitus (dm). |
PubMedID- 22327630 | Information on clinical variables (ie, dyslipidaemia, hypertension, smoking, diabetes mellitus, family history of coronary artery disease (cad), indication for pci, previous myocardial infarction (mi), previous coronary artery bypass graft surgery, previous pci, multivessel disease and left ventricular ejection fraction (lvef)) were prospectively collected at the time of the procedure and recorded in the institutional database. |
PubMedID- PMC2934129 | The most common single etiology was vavular heart disease, the most common triple etiology was coronary artery disease complicated with hypertension and diabetes mellitus. |
PubMedID- 23153979 | This study determined the role of endothelial nitric oxide synthase (enos) glu298asp polymorphism and intergenotypic variation of plasma nitric oxide (no) levels in coronary artery disease (cad) patients with type 2 diabetes mellitus (dm). |
PubMedID- 26161102 | In accordance with the requirement for uniform reporting standards [17], the following parameters were analyzed: age, gender, smoking habits, hypertension, dyslipidemia (defined as increased blood low-density lipoprotein (ldl) cholesterol concentration above 100 mg/dl, and/or triglyceride blood concentration above 150 mg/dl, or hypolipemic treatment on admission for a first endovascular procedure), diabetes mellitus, a history of coronary artery disease (cad), percutaneous coronary intervention (pci), a coronary artery bypass graft (cabg), congestive heart failure (chf), stroke, chronic kidney disease with a blood creatinine level of > 2 mg/dl, weight, height, body mass index (bmi), bilateral ankle-brachial index (abi), and claudication distance. |
PubMedID- 22048611 | The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. |
PubMedID- 20519088 | Clinical manifestations and risk factors of coronary artery disease in patients with diabetes mellitus in western siberia. |
PubMedID- 26295080 | Medical management of peripheral artery disease in diabetes mellitus. |
PubMedID- 20221852 | Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. |
PubMedID- 24063840 | Comparison of zotarolimus-eluting stent versus sirolimus-eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the essence-diabetes ii trial. |
PubMedID- 25042974 | [prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in primary care]. |
PubMedID- 23609464 | Serum s100a12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus. |
PubMedID- 24169284 | [effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus]. |
PubMedID- 23062567 | Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating "sick fat" through improving fat function with antidiabetes therapies. |
PubMedID- 25438840 | Diagnostic power of longitudinal strain at rest for the detection of obstructive coronary artery disease in patients with type 2 diabetes mellitus. |
PubMedID- 24819198 | Although revascularization through balloon dilatation or stent placemet would ameliorate coronary artery disease, patients with diabetes mellitus experienced worse outcomes than non-diabetic patients [2]. |
PubMedID- 20229160 | [revascularization of coronary artery disease in diabetes mellitus]. |
PubMedID- 22868391 | These guidelines recommend more aggressive control of blood pressure (bp <130/80 mm hg) among those at high risk for coronary artery disease, individuals with diabetes mellitus, chronic kidney disease, coronary artery disease or coronary artery disease risk equivalent, or a 10-year framingham risk score >/=10%. |
PubMedID- 23597770 | Patients with type 2 diabetes mellitus without evidence of coronary artery disease were recruited. |
PubMedID- 26265234 | Investigation of mda-ldl (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus. |
PubMedID- 21810659 | Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (essence-diabetes): results from the essence-diabetes trial. |
PubMedID- 21034455 | Background: the aim of the present cross-sectional study was to assess possible associations between osteopontin (opn), and thrombin-cleaved (n-half) opn, and nephropathy and coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
PubMedID- 23474620 | Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus. |
PubMedID- 23018602 | Objectives: this study aimed to compare the value of serum glycated albumin (ga) level versus glycated hemoglobin a(1c) (hba(1c)) for evaluating the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
PubMedID- 23389094 | We compared midterm prognostic predictors of peripheral artery disease (pad) with or without diabetes mellitus (dm) presenting with critical lower limb ischemia (cli). |
PubMedID- 20225090 | Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus. |
PubMedID- 20376883 | Preoperative risk factors for coronary artery disease included diabetes mellitus in 32 patients, hypertension in 60 patients, smoking in 63 patients, obesity in 5 patients, family history of coronary artery disease in 2 patients, and hypercholesterolemia in 33 patients (table 2). |
PubMedID- 23184484 | Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation. |
PubMedID- 21349201 | The objective of this study was to assess the relationship between glycemic variability determined by a continuous glucose monitoring (cgm) system and the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
PubMedID- 21200101 | Results: the two groups were similar with regard to age, gender, hypertension, diabetes mellitus, family history of coronary artery disease, smoking, and alcohol consumption. |
Page: 1 2